These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7378257)

  • 1. Roles of hepatic blood flow and enzyme activity in the kinetics of propranolol and sotalol.
    Pirttiaho HI; Sotaniemi EA; Pelkonen RO; Pitkänen U; Anttila M; Sundqvist H
    Br J Clin Pharmacol; 1980 Apr; 9(4):399-405. PubMed ID: 7378257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma clearance of propranolol and sotalol and hepatic drug-metabolizing enzyme activity.
    Sotaniemi EA; Anttila M; Pelkonen RO; Järvensivu P; Sundquist H
    Clin Pharmacol Ther; 1979 Aug; 26(2):153-61. PubMed ID: 455885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of propranolol and sotalol in hyperthyroidism.
    Aro A; Anttila M; Korhonen T; Sundquist H
    Eur J Clin Pharmacol; 1982; 21(5):373-7. PubMed ID: 7075642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants.
    Pirttiaho HI; Sotaniemi EA; Pelkonen RO; Pitkänen U
    Eur J Clin Pharmacol; 1982; 22(5):441-5. PubMed ID: 7117357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
    Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propranolol and sotalol metabolism after a drinking party.
    Sotaniemi EA; Anttila M; Rautio A; Stengård J; Saukko P; Järvensivu P
    Clin Pharmacol Ther; 1981 Jun; 29(6):705-10. PubMed ID: 7226702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired elimination of propranolol due to right heart failure: drug clearance in the isolated liver and its relationship to intrinsic metabolic capacity.
    Ng CY; Ghabrial H; Morgan DJ; Ching MS; Smallwood RA; Angus PW
    Drug Metab Dispos; 2000 Oct; 28(10):1217-21. PubMed ID: 10997943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver drug metabolism and blood pressure response to a lipophilic and hydrophilic beta blocker.
    Säkö S; Sotaniemi EA; Anttila M
    Eur J Drug Metab Pharmacokinet; 1986; 11(2):81-6. PubMed ID: 3770017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose kinetics of oral propranolol, metoprolol, atenolol, and sotalol: relation to lipophilicity.
    Ochs HR; Greenblatt DJ; Arendt RM; Schäfer-Korting M; Mutschler E
    Arzneimittelforschung; 1985; 35(10):1580-2. PubMed ID: 2866772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of route of administration and blood flow on hepatic drug elimination.
    Shand DG; Kornhauser DM; Wilkinson GR
    J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enprostil, in contrast to cimetidine, does not inhibit propranolol metabolism.
    Reilly CS; Biollaz J; Koshakji RP; Wood AJ
    Clin Pharmacol Ther; 1986 Jul; 40(1):37-41. PubMed ID: 3087677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenoceptor blocking drugs and cytochrome P-450: the influence of propranolol treatment on caffeine, antipyrine, D-glucaric acid and indocyanine green elimination in patients with hepatic disorders.
    Traeger A; Horváth T; Rechenbach C; Jávor T
    Int J Clin Pharmacol Res; 1986; 6(3):235-9. PubMed ID: 3744626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfer of propranolol and sotalol across the human placenta. Their effect on maternal and fetal plasma renin activity.
    Erkkola R; Lammintausta R; Liukko P; Anttila M
    Acta Obstet Gynecol Scand; 1982; 61(1):31-4. PubMed ID: 7046334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of liver blood flow and propranolol metabolism by cimetidine.
    Feely J; Wilkinson GR; Wood AJ
    N Engl J Med; 1981 Mar; 304(12):692-5. PubMed ID: 7464861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (+)-Propranolol clearance, an estimation of hepatic blood flow in man.
    Weiss YA; Safar ME; Lehner JP; Levenson JA; Simon A; Alexandre JM
    Br J Clin Pharmacol; 1978 May; 5(5):457-60. PubMed ID: 656285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic drug interactions with propranolol.
    Wood AJ; Feely J
    Clin Pharmacokinet; 1983; 8(3):253-62. PubMed ID: 6342901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced hepatic clearance of propranolol induced by chronic carbon tetrachloride treatment in rats.
    Iwamoto K; Watanabe J; Araki K; Satoh M; Deguchi N
    J Pharmacol Exp Ther; 1985 Aug; 234(2):470-5. PubMed ID: 4020680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver size and indices of drug metabolism in epileptics.
    Pirttiaho HI; Sotaniemi EA; Ahokas JT; Pitkänen U
    Br J Clin Pharmacol; 1978 Sep; 6(3):273-8. PubMed ID: 687506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, central nervous system uptake, and lipid solubility of propranolol, acebutolol, and sotalol.
    Arendt RM; Greenblatt DJ; deJong RH; Bonin JD; Abernethy DR
    Cardiology; 1984; 71(6):307-14. PubMed ID: 6151871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.